FdaApplication
NDA 213536
Identifiers
- fda_app_no: NDA213536
Properties
| Property | Value |
|---|---|
| applicant_name | DR REDDYS LABORATORIES SA |
| application_type | NDA |
| approval_date | 2021-06-14 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REZIPRES | EPHEDRINE HYDROCHLORIDE | 47MG/5ML (9.4MG/ML) | SOLUTION;INTRAVENOUS |
| REZIPRES | EPHEDRINE HYDROCHLORIDE | 47MG/ML (47MG/ML) | SOLUTION;INTRAVENOUS |
| REZIPRES | EPHEDRINE HYDROCHLORIDE | 47MG/10ML (4.7MG/ML) | SOLUTION;INTRAVENOUS |
| REZIPRES | EPHEDRINE HYDROCHLORIDE | 23.5MG/5ML (4.7MG/ML) | SOLUTION;INTRAVENOUS |
4 products